Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases

Background Total liver volume (TLV) empirically changes after aggressive preoperative chemotherapy for colorectal liver metastases (CLM). However, the actual degree of changes in normal liver parenchyma and its clinical relevance remain unclear. Methods Morphometric data of 110 patients who underwen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastrointestinal surgery 2017-05, Vol.21 (5), p.813-821
Hauptverfasser: Tani, Keigo, Shindoh, Junichi, Takamoto, Takeshi, Shibahara, Junji, Nishioka, Yujiro, Hashimoto, Takuya, Sakamoto, Yoshihiro, Hasegawa, Kiyoshi, Makuuchi, Masatoshi, Kokudo, Norihiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 821
container_issue 5
container_start_page 813
container_title Journal of gastrointestinal surgery
container_volume 21
creator Tani, Keigo
Shindoh, Junichi
Takamoto, Takeshi
Shibahara, Junji
Nishioka, Yujiro
Hashimoto, Takuya
Sakamoto, Yoshihiro
Hasegawa, Kiyoshi
Makuuchi, Masatoshi
Kokudo, Norihiro
description Background Total liver volume (TLV) empirically changes after aggressive preoperative chemotherapy for colorectal liver metastases (CLM). However, the actual degree of changes in normal liver parenchyma and its clinical relevance remain unclear. Methods Morphometric data of 110 patients who underwent initial hepatectomy after preoperative chemotherapy were reviewed. TLVs before and after chemotherapy were measured using a computer-based volumetry software and their relevance to clinical factors was investigated. Results More than 10% of decrease in TLV was observed in 42 (38.2%) patients, and more than 10% of increase was observed in 11 (10.0%) patients. Change in TLV was within 10% in the remaining 57 (51.8%) patients. Indocyanine green retention rate at 15 min (ICG-R15) value was significantly higher in patients with TLV decrease more than 10% (13.4 vs. 9.3 vs. 8.5%; p  = 0.004). Steatosis in the underlying liver was significantly frequent in patients with TLV increase more than 10% ( p  15% (odds ratio 8.8; p  = 0.0001). Tendency of correlation was confirmed in the kinetic changes in TLV and ICG-R15 during chemotherapy even though there was no statistical significance ( r  = −0.33, p  = 0.080). Conclusion Perichemotherapy kinetic changes in TLV may predict histopathologic changes or changes in hepatic functional reserve in the underlying liver. More than 10% of shrinkage in TLV is associated with impaired hepatic functional reserve, and it can be a new supplemental finding in the prediction of surgical risk of major hepatectomy for CLM.
doi_str_mv 10.1007/s11605-017-3359-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1890809407</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4321898733</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-3266ba05c263516fbc279da15f8cc2ddbfdc646ccdeb28e221f55f9c8b3674943</originalsourceid><addsrcrecordid>eNp1kMtKAzEUhoMotlYfwI0MuB7NZZLJLEvxhhVdKLgLmcyJndK5NEmVvr0ZWsWNEDjJOV_-Ax9C5wRfEYzza0-IwDzFJE8Z40WaHaAxkTlLM0HFYbzjgqSU8_cROvF-iSOIiTxGIyqxZJLlY7R-rFsItUlmC91-gE_qNpnXn-CSF-2gNYtto5OpDUPDQdeD0yGOIw5NFxbx2W8T2w14qKENPvmqwyKZdavOgQl6tU97gqB9POBP0ZHVKw9n-zpBb7c3r7P7dP589zCbzlPDchpSRoUoNeaGCsaJsKWheVFpwq00hlZVaSsjMmFMBSWVQCmxnNvCyJKJPCsyNkGXu9zedesN-KCW3ca1caUissASFxnOI0V2lHGd9w6s6l3daLdVBKtBstpJVtGdGiSrIflin7wpG6h-f_xYjQDdAT6OolX3Z_W_qd-nBYkI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1890809407</pqid></control><display><type>article</type><title>Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Tani, Keigo ; Shindoh, Junichi ; Takamoto, Takeshi ; Shibahara, Junji ; Nishioka, Yujiro ; Hashimoto, Takuya ; Sakamoto, Yoshihiro ; Hasegawa, Kiyoshi ; Makuuchi, Masatoshi ; Kokudo, Norihiro</creator><creatorcontrib>Tani, Keigo ; Shindoh, Junichi ; Takamoto, Takeshi ; Shibahara, Junji ; Nishioka, Yujiro ; Hashimoto, Takuya ; Sakamoto, Yoshihiro ; Hasegawa, Kiyoshi ; Makuuchi, Masatoshi ; Kokudo, Norihiro</creatorcontrib><description>Background Total liver volume (TLV) empirically changes after aggressive preoperative chemotherapy for colorectal liver metastases (CLM). However, the actual degree of changes in normal liver parenchyma and its clinical relevance remain unclear. Methods Morphometric data of 110 patients who underwent initial hepatectomy after preoperative chemotherapy were reviewed. TLVs before and after chemotherapy were measured using a computer-based volumetry software and their relevance to clinical factors was investigated. Results More than 10% of decrease in TLV was observed in 42 (38.2%) patients, and more than 10% of increase was observed in 11 (10.0%) patients. Change in TLV was within 10% in the remaining 57 (51.8%) patients. Indocyanine green retention rate at 15 min (ICG-R15) value was significantly higher in patients with TLV decrease more than 10% (13.4 vs. 9.3 vs. 8.5%; p  = 0.004). Steatosis in the underlying liver was significantly frequent in patients with TLV increase more than 10% ( p  &lt; 0.001). Multivariate logistic regression analysis revealed that more than 10% of shrinkage in TLV after chemotherapy was independently associated with ICG-R15 &gt;15% (odds ratio 8.8; p  = 0.0001). Tendency of correlation was confirmed in the kinetic changes in TLV and ICG-R15 during chemotherapy even though there was no statistical significance ( r  = −0.33, p  = 0.080). Conclusion Perichemotherapy kinetic changes in TLV may predict histopathologic changes or changes in hepatic functional reserve in the underlying liver. More than 10% of shrinkage in TLV is associated with impaired hepatic functional reserve, and it can be a new supplemental finding in the prediction of surgical risk of major hepatectomy for CLM.</description><identifier>ISSN: 1091-255X</identifier><identifier>EISSN: 1873-4626</identifier><identifier>DOI: 10.1007/s11605-017-3359-4</identifier><identifier>PMID: 28083837</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents - adverse effects ; Chemotherapy ; Colorectal Neoplasms - diagnostic imaging ; Colorectal Neoplasms - pathology ; Colorectal Neoplasms - surgery ; Coloring Agents ; Female ; Gastroenterology ; Hepatectomy ; Hospitals ; Humans ; Imaging, Three-Dimensional ; Indocyanine Green ; Liver - diagnostic imaging ; Liver - drug effects ; Liver - pathology ; Liver cirrhosis ; Liver Neoplasms - diagnostic imaging ; Liver Neoplasms - pathology ; Liver Neoplasms - secondary ; Liver Neoplasms - surgery ; Male ; Medicine ; Medicine &amp; Public Health ; Metastasis ; Middle Aged ; Neoadjuvant Therapy - adverse effects ; Organ Size - drug effects ; Original Article ; Preoperative Care ; Risk Assessment ; Risk Factors ; Software ; Surgery ; Tomography, X-Ray Computed ; Tumors ; Volumetric analysis ; Young Adult</subject><ispartof>Journal of gastrointestinal surgery, 2017-05, Vol.21 (5), p.813-821</ispartof><rights>The Society for Surgery of the Alimentary Tract 2017</rights><rights>Journal of Gastrointestinal Surgery is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-3266ba05c263516fbc279da15f8cc2ddbfdc646ccdeb28e221f55f9c8b3674943</citedby><cites>FETCH-LOGICAL-c372t-3266ba05c263516fbc279da15f8cc2ddbfdc646ccdeb28e221f55f9c8b3674943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11605-017-3359-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11605-017-3359-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28083837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tani, Keigo</creatorcontrib><creatorcontrib>Shindoh, Junichi</creatorcontrib><creatorcontrib>Takamoto, Takeshi</creatorcontrib><creatorcontrib>Shibahara, Junji</creatorcontrib><creatorcontrib>Nishioka, Yujiro</creatorcontrib><creatorcontrib>Hashimoto, Takuya</creatorcontrib><creatorcontrib>Sakamoto, Yoshihiro</creatorcontrib><creatorcontrib>Hasegawa, Kiyoshi</creatorcontrib><creatorcontrib>Makuuchi, Masatoshi</creatorcontrib><creatorcontrib>Kokudo, Norihiro</creatorcontrib><title>Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases</title><title>Journal of gastrointestinal surgery</title><addtitle>J Gastrointest Surg</addtitle><addtitle>J Gastrointest Surg</addtitle><description>Background Total liver volume (TLV) empirically changes after aggressive preoperative chemotherapy for colorectal liver metastases (CLM). However, the actual degree of changes in normal liver parenchyma and its clinical relevance remain unclear. Methods Morphometric data of 110 patients who underwent initial hepatectomy after preoperative chemotherapy were reviewed. TLVs before and after chemotherapy were measured using a computer-based volumetry software and their relevance to clinical factors was investigated. Results More than 10% of decrease in TLV was observed in 42 (38.2%) patients, and more than 10% of increase was observed in 11 (10.0%) patients. Change in TLV was within 10% in the remaining 57 (51.8%) patients. Indocyanine green retention rate at 15 min (ICG-R15) value was significantly higher in patients with TLV decrease more than 10% (13.4 vs. 9.3 vs. 8.5%; p  = 0.004). Steatosis in the underlying liver was significantly frequent in patients with TLV increase more than 10% ( p  &lt; 0.001). Multivariate logistic regression analysis revealed that more than 10% of shrinkage in TLV after chemotherapy was independently associated with ICG-R15 &gt;15% (odds ratio 8.8; p  = 0.0001). Tendency of correlation was confirmed in the kinetic changes in TLV and ICG-R15 during chemotherapy even though there was no statistical significance ( r  = −0.33, p  = 0.080). Conclusion Perichemotherapy kinetic changes in TLV may predict histopathologic changes or changes in hepatic functional reserve in the underlying liver. More than 10% of shrinkage in TLV is associated with impaired hepatic functional reserve, and it can be a new supplemental finding in the prediction of surgical risk of major hepatectomy for CLM.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Chemotherapy</subject><subject>Colorectal Neoplasms - diagnostic imaging</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Colorectal Neoplasms - surgery</subject><subject>Coloring Agents</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Hepatectomy</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Imaging, Three-Dimensional</subject><subject>Indocyanine Green</subject><subject>Liver - diagnostic imaging</subject><subject>Liver - drug effects</subject><subject>Liver - pathology</subject><subject>Liver cirrhosis</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - secondary</subject><subject>Liver Neoplasms - surgery</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Neoadjuvant Therapy - adverse effects</subject><subject>Organ Size - drug effects</subject><subject>Original Article</subject><subject>Preoperative Care</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Software</subject><subject>Surgery</subject><subject>Tomography, X-Ray Computed</subject><subject>Tumors</subject><subject>Volumetric analysis</subject><subject>Young Adult</subject><issn>1091-255X</issn><issn>1873-4626</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kMtKAzEUhoMotlYfwI0MuB7NZZLJLEvxhhVdKLgLmcyJndK5NEmVvr0ZWsWNEDjJOV_-Ax9C5wRfEYzza0-IwDzFJE8Z40WaHaAxkTlLM0HFYbzjgqSU8_cROvF-iSOIiTxGIyqxZJLlY7R-rFsItUlmC91-gE_qNpnXn-CSF-2gNYtto5OpDUPDQdeD0yGOIw5NFxbx2W8T2w14qKENPvmqwyKZdavOgQl6tU97gqB9POBP0ZHVKw9n-zpBb7c3r7P7dP589zCbzlPDchpSRoUoNeaGCsaJsKWheVFpwq00hlZVaSsjMmFMBSWVQCmxnNvCyJKJPCsyNkGXu9zedesN-KCW3ca1caUissASFxnOI0V2lHGd9w6s6l3daLdVBKtBstpJVtGdGiSrIflin7wpG6h-f_xYjQDdAT6OolX3Z_W_qd-nBYkI</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Tani, Keigo</creator><creator>Shindoh, Junichi</creator><creator>Takamoto, Takeshi</creator><creator>Shibahara, Junji</creator><creator>Nishioka, Yujiro</creator><creator>Hashimoto, Takuya</creator><creator>Sakamoto, Yoshihiro</creator><creator>Hasegawa, Kiyoshi</creator><creator>Makuuchi, Masatoshi</creator><creator>Kokudo, Norihiro</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20170501</creationdate><title>Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases</title><author>Tani, Keigo ; Shindoh, Junichi ; Takamoto, Takeshi ; Shibahara, Junji ; Nishioka, Yujiro ; Hashimoto, Takuya ; Sakamoto, Yoshihiro ; Hasegawa, Kiyoshi ; Makuuchi, Masatoshi ; Kokudo, Norihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-3266ba05c263516fbc279da15f8cc2ddbfdc646ccdeb28e221f55f9c8b3674943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Chemotherapy</topic><topic>Colorectal Neoplasms - diagnostic imaging</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Colorectal Neoplasms - surgery</topic><topic>Coloring Agents</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Hepatectomy</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Imaging, Three-Dimensional</topic><topic>Indocyanine Green</topic><topic>Liver - diagnostic imaging</topic><topic>Liver - drug effects</topic><topic>Liver - pathology</topic><topic>Liver cirrhosis</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - secondary</topic><topic>Liver Neoplasms - surgery</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Neoadjuvant Therapy - adverse effects</topic><topic>Organ Size - drug effects</topic><topic>Original Article</topic><topic>Preoperative Care</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Software</topic><topic>Surgery</topic><topic>Tomography, X-Ray Computed</topic><topic>Tumors</topic><topic>Volumetric analysis</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tani, Keigo</creatorcontrib><creatorcontrib>Shindoh, Junichi</creatorcontrib><creatorcontrib>Takamoto, Takeshi</creatorcontrib><creatorcontrib>Shibahara, Junji</creatorcontrib><creatorcontrib>Nishioka, Yujiro</creatorcontrib><creatorcontrib>Hashimoto, Takuya</creatorcontrib><creatorcontrib>Sakamoto, Yoshihiro</creatorcontrib><creatorcontrib>Hasegawa, Kiyoshi</creatorcontrib><creatorcontrib>Makuuchi, Masatoshi</creatorcontrib><creatorcontrib>Kokudo, Norihiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Journal of gastrointestinal surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tani, Keigo</au><au>Shindoh, Junichi</au><au>Takamoto, Takeshi</au><au>Shibahara, Junji</au><au>Nishioka, Yujiro</au><au>Hashimoto, Takuya</au><au>Sakamoto, Yoshihiro</au><au>Hasegawa, Kiyoshi</au><au>Makuuchi, Masatoshi</au><au>Kokudo, Norihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases</atitle><jtitle>Journal of gastrointestinal surgery</jtitle><stitle>J Gastrointest Surg</stitle><addtitle>J Gastrointest Surg</addtitle><date>2017-05-01</date><risdate>2017</risdate><volume>21</volume><issue>5</issue><spage>813</spage><epage>821</epage><pages>813-821</pages><issn>1091-255X</issn><eissn>1873-4626</eissn><abstract>Background Total liver volume (TLV) empirically changes after aggressive preoperative chemotherapy for colorectal liver metastases (CLM). However, the actual degree of changes in normal liver parenchyma and its clinical relevance remain unclear. Methods Morphometric data of 110 patients who underwent initial hepatectomy after preoperative chemotherapy were reviewed. TLVs before and after chemotherapy were measured using a computer-based volumetry software and their relevance to clinical factors was investigated. Results More than 10% of decrease in TLV was observed in 42 (38.2%) patients, and more than 10% of increase was observed in 11 (10.0%) patients. Change in TLV was within 10% in the remaining 57 (51.8%) patients. Indocyanine green retention rate at 15 min (ICG-R15) value was significantly higher in patients with TLV decrease more than 10% (13.4 vs. 9.3 vs. 8.5%; p  = 0.004). Steatosis in the underlying liver was significantly frequent in patients with TLV increase more than 10% ( p  &lt; 0.001). Multivariate logistic regression analysis revealed that more than 10% of shrinkage in TLV after chemotherapy was independently associated with ICG-R15 &gt;15% (odds ratio 8.8; p  = 0.0001). Tendency of correlation was confirmed in the kinetic changes in TLV and ICG-R15 during chemotherapy even though there was no statistical significance ( r  = −0.33, p  = 0.080). Conclusion Perichemotherapy kinetic changes in TLV may predict histopathologic changes or changes in hepatic functional reserve in the underlying liver. More than 10% of shrinkage in TLV is associated with impaired hepatic functional reserve, and it can be a new supplemental finding in the prediction of surgical risk of major hepatectomy for CLM.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>28083837</pmid><doi>10.1007/s11605-017-3359-4</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1091-255X
ispartof Journal of gastrointestinal surgery, 2017-05, Vol.21 (5), p.813-821
issn 1091-255X
1873-4626
language eng
recordid cdi_proquest_journals_1890809407
source MEDLINE; SpringerLink Journals
subjects Adult
Aged
Aged, 80 and over
Antineoplastic Agents - adverse effects
Chemotherapy
Colorectal Neoplasms - diagnostic imaging
Colorectal Neoplasms - pathology
Colorectal Neoplasms - surgery
Coloring Agents
Female
Gastroenterology
Hepatectomy
Hospitals
Humans
Imaging, Three-Dimensional
Indocyanine Green
Liver - diagnostic imaging
Liver - drug effects
Liver - pathology
Liver cirrhosis
Liver Neoplasms - diagnostic imaging
Liver Neoplasms - pathology
Liver Neoplasms - secondary
Liver Neoplasms - surgery
Male
Medicine
Medicine & Public Health
Metastasis
Middle Aged
Neoadjuvant Therapy - adverse effects
Organ Size - drug effects
Original Article
Preoperative Care
Risk Assessment
Risk Factors
Software
Surgery
Tomography, X-Ray Computed
Tumors
Volumetric analysis
Young Adult
title Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T05%3A08%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kinetic%20Changes%20in%20Liver%20Parenchyma%20After%20Preoperative%20Chemotherapy%20for%20Patients%20with%20Colorectal%20Liver%20Metastases&rft.jtitle=Journal%20of%20gastrointestinal%20surgery&rft.au=Tani,%20Keigo&rft.date=2017-05-01&rft.volume=21&rft.issue=5&rft.spage=813&rft.epage=821&rft.pages=813-821&rft.issn=1091-255X&rft.eissn=1873-4626&rft_id=info:doi/10.1007/s11605-017-3359-4&rft_dat=%3Cproquest_cross%3E4321898733%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1890809407&rft_id=info:pmid/28083837&rfr_iscdi=true